Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

about

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

Item

http://www.wikidata.org/entity/Q45874429

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

@en

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

@nl

type

Item

label

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

@en

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

@nl

prefLabel

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

@en

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

@nl

P1476

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa.

@en

P2093

Janice Lamb

http://www.w3.org/2001/XMLSchema#string

Joan M Korth-Bradley

http://www.w3.org/2001/XMLSchema#string

Joanne Fuiman

http://www.w3.org/2001/XMLSchema#string

Lynne Smith

http://www.w3.org/2001/XMLSchema#string

Pablo Rendo

http://www.w3.org/2001/XMLSchema#string

P2860

Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals.

The hemophilias--from royal genes to gene therapy.

D-dimer assays in diagnosis and management of thrombotic and bleeding disorders.

Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.

Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.

Thrombogenicity associated with factor IX complex concentrates.

Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease.

Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies.

How I diagnose acute pulmonary embolism.

Current management of hemophilia B: recommendations, complications and emerging issues.

P304

81-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MBC.0000000000000681

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29135476

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

hemophilia B

P932

5794232

http://www.w3.org/2001/XMLSchema#string